Literature DB >> 26100017

RNA-Binding Protein Musashi1 Is a Central Regulator of Adhesion Pathways in Glioblastoma.

Philip J Uren1, Dat T Vo2, Patricia Rosa de Araujo2, Rebecca Pötschke3, Suzanne C Burns4, Emad Bahrami-Samani1, Mei Qiao4, Raquel de Sousa Abreu4, Helder I Nakaya5, Bruna R Correa4, Caspar Kühnöl3, Jernej Ule6, Jennifer L Martindale7, Kotb Abdelmohsen7, Myriam Gorospe7, Andrew D Smith8, Luiz O F Penalva9.   

Abstract

The conserved RNA-binding protein Musashi1 (MSI1) has emerged as a key oncogenic factor in numerous solid tumors, including glioblastoma. However, its mechanism of action has not yet been established comprehensively. To identify its target genes comprehensively and determine the main routes by which it influences glioblastoma phenotypes, we conducted individual-nucleotide resolution cross-linking and immunoprecipitation (iCLIP) experiments. We confirmed that MSI1 has a preference for UAG sequences contained in a particular structural context, especially in 3' untranslated regions. Although numerous binding sites were also identified in intronic sequences, our RNA transcriptome sequencing analysis does not favor the idea that MSI1 is a major regulator of splicing in glioblastoma cells. MSI1 target mRNAs encode proteins that function in multiple pathways of cell proliferation and cell adhesion. Since these associations indicate potentially new roles for MSI1, we investigated its impact on glioblastoma cell adhesion, morphology, migration, and invasion. These processes are known to underpin the spread and relapse of glioblastoma, in contrast to other tumors where metastasis is the main driver of recurrence and progression.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26100017      PMCID: PMC4525321          DOI: 10.1128/MCB.00410-15

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  83 in total

1.  Musashi1, an evolutionarily conserved neural RNA-binding protein, is a versatile marker of human glioma cells in determining their cellular origin, malignancy, and proliferative activity.

Authors:  Y Kanemura; K Mori; S Sakakibara; H Fujikawa; H Hayashi; A Nakano; T Matsumoto; K Tamura; T Imai; T Ohnishi; S Fushiki; Y Nakamura; M Yamasaki; H Okano; N Arita
Journal:  Differentiation       Date:  2001-09       Impact factor: 3.880

2.  Expression of adhesion molecules and extracellular matrix proteins in glioblastomas: relation to angiogenesis and spread.

Authors:  D Vitolo; P Paradiso; S Uccini; L P Ruco; C D Baroni
Journal:  Histopathology       Date:  1996-06       Impact factor: 5.087

3.  Expression of neural RNA-binding proteins in the postnatal CNS: implications of their roles in neuronal and glial cell development.

Authors:  S Sakakibara; H Okano
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

Review 4.  Computational challenges, tools, and resources for analyzing co- and post-transcriptional events in high throughput.

Authors:  Emad Bahrami-Samani; Dat T Vo; Patricia Rosa de Araujo; Christine Vogel; Andrew D Smith; Luiz O F Penalva; Philip J Uren
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-12-16       Impact factor: 9.957

5.  The human Musashi homolog 1 (MSI1) gene encoding the homologue of Musashi/Nrp-1, a neural RNA-binding protein putatively expressed in CNS stem cells and neural progenitor cells.

Authors:  P Good; A Yoda; S Sakakibara; A Yamamoto; T Imai; H Sawa; T Ikeuchi; S Tsuji; H Satoh; H Okano
Journal:  Genomics       Date:  1998-09-15       Impact factor: 5.736

6.  Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo.

Authors:  Sripathi M Sureban; Randal May; Robert J George; Brian K Dieckgraefe; Howard L McLeod; Satish Ramalingam; Kumar S Bishnupuri; Gopalan Natarajan; Shrikant Anant; Courtney W Houchen
Journal:  Gastroenterology       Date:  2008-03-04       Impact factor: 22.682

Review 7.  Tumor suppressor CYLD: negative regulation of NF-kappaB signaling and more.

Authors:  G Courtois
Journal:  Cell Mol Life Sci       Date:  2008-04       Impact factor: 9.261

8.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.

Authors:  Michael I Love; Wolfgang Huber; Simon Anders
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

9.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

Review 10.  Musashi: a translational regulator of cell fate.

Authors:  Hideyuki Okano; Takao Imai; Masataka Okabe
Journal:  J Cell Sci       Date:  2002-04-01       Impact factor: 5.285

View more
  28 in total

Review 1.  Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets.

Authors:  Alexander E Kudinov; John Karanicolas; Erica A Golemis; Yanis Boumber
Journal:  Clin Cancer Res       Date:  2017-01-31       Impact factor: 12.531

2.  Musashi1 Impacts Radio-Resistance in Glioblastoma by Controlling DNA-Protein Kinase Catalytic Subunit.

Authors:  Patricia Rosa de Araujo; Aparna Gorthi; Acarizia E da Silva; Sonal S Tonapi; Dat T Vo; Suzanne C Burns; Mei Qiao; Philip J Uren; Zhi-Min Yuan; Alexander J R Bishop; Luiz O F Penalva
Journal:  Am J Pathol       Date:  2016-07-25       Impact factor: 4.307

3.  TUSC3 suppresses glioblastoma development by inhibiting Akt signaling.

Authors:  Zhenfeng Jiang; Mian Guo; Xiangtong Zhang; Lifen Yao; Jia Shen; Guizhen Ma; Li Liu; Liwei Zhao; Chuncheng Xie; Hongsheng Liang; Haiyang Wang; Minwei Zhu; Li Hu; Yuanyuan Song; Hong Shen; Zhiguo Lin
Journal:  Tumour Biol       Date:  2016-05-13

4.  PTB-AS, a Novel Natural Antisense Transcript, Promotes Glioma Progression by Improving PTBP1 mRNA Stability with SND1.

Authors:  Liyuan Zhu; Qunfang Wei; Yingjiao Qi; Xiangbin Ruan; Fan Wu; Liang Li; Junjie Zhou; Wei Liu; Tao Jiang; Jing Zhang; Bin Yin; Jiangang Yuan; Boqin Qiang; Wei Han; Xiaozhong Peng
Journal:  Mol Ther       Date:  2019-06-05       Impact factor: 11.454

Review 5.  The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies.

Authors:  Semer Maksoud
Journal:  Mol Neurobiol       Date:  2022-06-13       Impact factor: 5.682

6.  Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells.

Authors:  Caihong Yi; Guiming Li; Dmitri N Ivanov; Zhonghua Wang; Mitzli X Velasco; Greco Hernández; Soni Kaundal; Johanna Villarreal; Yogesh K Gupta; Mei Qiao; Christopher G Hubert; Matthew J Hart; Luiz O F Penalva
Journal:  RNA Biol       Date:  2018-11-18       Impact factor: 4.652

7.  Neurodevelopmental protein Musashi-1 interacts with the Zika genome and promotes viral replication.

Authors:  Pavithra L Chavali; Lovorka Stojic; Luke W Meredith; Nimesh Joseph; Michael S Nahorski; Thomas J Sanford; Trevor R Sweeney; Ben A Krishna; Myra Hosmillo; Andrew E Firth; Richard Bayliss; Carlo L Marcelis; Susan Lindsay; Ian Goodfellow; C Geoffrey Woods; Fanni Gergely
Journal:  Science       Date:  2017-06-01       Impact factor: 47.728

Review 8.  Musashi-1-A Stemness RBP for Cancer Therapy?

Authors:  Nadine Bley; Ali Hmedat; Simon Müller; Robin Rolnik; Alexander Rausch; Marcell Lederer; Stefan Hüttelmaier
Journal:  Biology (Basel)       Date:  2021-05-05

9.  The Musashi 1 Controls the Splicing of Photoreceptor-Specific Exons in the Vertebrate Retina.

Authors:  Daniel Murphy; Benjamin Cieply; Russ Carstens; Visvanathan Ramamurthy; Peter Stoilov
Journal:  PLoS Genet       Date:  2016-08-19       Impact factor: 5.917

10.  Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma.

Authors:  Bruna R Correa; Patricia Rosa de Araujo; Mei Qiao; Suzanne C Burns; Chen Chen; Richard Schlegel; Seema Agarwal; Pedro A F Galante; Luiz O F Penalva
Journal:  Genome Biol       Date:  2016-06-10       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.